BioTecNika - September 2014 - Ebola Special

Publisher: Biotecnika Info Labs Pvt Ltd
Category: Education, Technology
Language: English
Frequency : Monthly
Single issue $ 0.99 -

Subscribe to Magzter GOLD and enjoy Unlimited reading of BioTecNika Magazine (including old issues) along with 5,000+ other best-selling magazines and premium articles for just $9.99/Month!

When the wrath of deadly Ebola is showing its heinous side by causing a global pandemic and silently taking a toll on population across West African countries, finding a full stop to this problem is what scientists all across the globe are striving for. Biotechnology which has been the answer to many such unforeseen hurdles in the past is being looked upon with high expectations and why not! It has the potential to sway away many major problems. Biotecnika's September issue talks about the same and chalks out, 'If biotech biggies would churn out a remedy soon?' Other topics to interest our readers are 'The battle with HIV--when will we win?', Ban on GMO trials...where is the road taking us?' and much more..The issue also interacted with biotech big names such as Biocon Academy, Stempeutics and Sigma Aldrich to know the industry better. Wait no more and grab your copy of Biotecnika magazine now!

The essential guide to all the news in biotechnology industry & Academia run by India's Most popular Biotechnology Portal BioTecNika has access to world’s most influential Biotech entrepreneurs, Businesses and institutions. The magazine showcases all this via exclusive features that are insightful, informative and presented with style. Distinguished by its indepth analysis and latest information, BioTecNika has been an indispensable part of life of Biotechies for over 8+ years. Our well-heeled readership shape opinions and trends in India and across the region. This affluent and influential group is almost impossible to reach - except through the pages of BioTecNika

Recent Issues

View All

Magazines from Education

View All

Magazines from Technology

View All